- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05396599
A Clinical Study Comparing Postoperative Outcomes Between the TECNIS Intraocular Lens.
April 26, 2023 updated by: Johnson & Johnson Surgical Vision, Inc.
A Clinical Study Comparing Postoperative Outcomes Between the TECNIS Eyhance™ Toric II Intraocular Lens With TECNIS Simplicity Delivery System, Model Series DIU and the TECNIS Synergy® Toric II Intraocular Lens With TECNIS Simplicity Delivery System, Model Series DFW to the TECNIS® Toric Intraocular Lens Model Series ZCT
This is a prospective, multi-center, masked, three-arm, randomized clinical study of the TECNIS Eyhance Toric II IOL (test #1) and TECNIS Synergy Toric II (test #2) compared to the TECNIS Toric 1-Piece IOL (control).
Study Overview
Status
Terminated
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
37
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Study Contact
- Phone Number: 714-679-8508
- Email: LConnol1@its.jnj.com
Study Locations
-
-
California
-
Los Angeles, California, United States, 91325
- Shultz Chang Vision
-
Orange, California, United States, 92868
- Coastal Vision
-
San Francisco, California, United States, 94115
- Pacific Eye Associates, A Medical Corporation
-
-
Hawaii
-
Honolulu, Hawaii, United States, 96817
- Aloha Vision Consultants
-
-
Texas
-
San Antonio, Texas, United States, 78229
- Parkhurst NuVision
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
22 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
Eligible subjects will be enrolled based on surgeon's determination of meeting the minimum study criteria in one or both eyes:
- Male or female at least 22 years of age
- Have a cataract in one or both eyes, with planned phacoemulsification and intraocular lens implantation with a toric intraocular lens
- Regular corneal astigmatism and predicted postoperative residual astigmatism of less than 1.00 D after implantation with a toric intraocular lens in the study eye(s)
- Availability, willingness and sufficient cognitive awareness to understand the purpose of the examination procedures and comply with postoperative visits
- Signed informed consent and HIPAA authorization or equivalent documentation necessary to comply with applicable privacy laws pertaining to medical treatment in the governing countries.
Exclusion Criteria:
Eligible subjects will be enrolled based on surgeon's determination of meeting the minimum study criteria in one or both eyes:
- Best-corrected distance visual acuity better than 20/40 Snellen (0.3 logMAR)
- Potential visual acuity estimated to be worse than 20/32 Snellen (0.2 logMAR)
- Prior corneal refractive (LASIK, LASEK, RK, PRK, etc.) or intraocular surgery, Including prophylactic peripheral iridotomies and peripheral laser retinal repairs
- Corneal abnormalities such as stromal, epithelial or endothelial dystrophies (e.g., any observed guttata) that are predicted to cause visual acuity losses to a level worse than 20/30 Snellen during the study
- Pupil abnormalities (non-reactive, fixed pupils, or abnormally shaped pupils) or unable to dilate to visualize IOL axis (approximately 6.0 mm)
- Inability to achieve keratometric stability for contact lens wearers (as defined in Section 10.3 Preoperative Procedures)
- Recent ocular trauma or ocular surgery that is not resolved/stable or may affect visual outcomes or increase risk to the subject
- Use of systemic or ocular medications that may affect vision
- Prior, current, or anticipated use during the course of the 6-month study of tamsulosin or silodosin (e.g., Flomax, Flomaxtra, Rapaflo) that may, in the opinion of the investigator, confound the outcome or increase the risk to the subject (e.g., poor dilation or a lack of adequate iris structure to perform standard cataract surgery)
- Poorly controlled diabetes
- Acute, chronic, or uncontrolled systemic or ocular disease or illness that, in the opinion of the investigator, would increase the operative risk or confound the outcome(s) of the study (e.g., immunocompromised, connective tissue disease, suspected glaucoma, glaucomatous changes in the fundus or visual field, ocular inflammation, etc.). Note: controlled ocular hypertension without glaucomatous changes (optic nerve cupping and visual field loss) is acceptable.
- Pregnancy, planned pregnancy, presently lactating, or another condition associated with hormonal fluctuation that could lead to refractive changes
- Concurrent participation or participation in any other clinical study within 30 days prior to the preoperative visit
- Any other systemic or ocular disease that, in the opinion of the investigator, may affect the patient's eligibility for the study, affect visual acuity or may require surgical intervention during the study (e.g., macular degeneration, cystoid macular edema, diabetic retinopathy, etc.).
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Eyhance Toric II IOL
Model DIU
|
Subjects will be randomized to a treatment group (masked) in ratio 1:1:1.
Surgeons will perform standardized, small-incision, cataract surgery and implant the study lenses using a JJSV-validated insertion system qualified for use with the lens to be implanted.
|
Experimental: TECNIS Synergy Toric II
Model DFW
|
Subjects will be randomized to a treatment group (masked) in ratio 1:1:1.
Surgeons will perform standardized, small-incision, cataract surgery and implant the study lenses using a JJSV-validated insertion system qualified for use with the lens to be implanted.
|
Active Comparator: TECNIS Toric 1-Piece IOL
Model ZCT
|
Subjects will be randomized to a treatment group (masked) in ratio 1:1:1.
Surgeons will perform standardized, small-incision, cataract surgery and implant the study lenses using a JJSV-validated insertion system qualified for use with the lens to be implanted.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Rotational Stability of IOL
Time Frame: 6-months post-operative
|
The percentage of eyes with rotational stability of the IOL at postoperative 6 months
|
6-months post-operative
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Study Director: Johnson & Johnson Surgical Vision, Inc. Clinical Trial, Johnson & Johnson Surgical Vision, Inc.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 30, 2022
Primary Completion (Actual)
April 7, 2023
Study Completion (Actual)
April 7, 2023
Study Registration Dates
First Submitted
May 25, 2022
First Submitted That Met QC Criteria
May 25, 2022
First Posted (Actual)
May 31, 2022
Study Record Updates
Last Update Posted (Actual)
April 28, 2023
Last Update Submitted That Met QC Criteria
April 26, 2023
Last Verified
April 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- JJSV201EYST
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
Johnson & Johnson Medical Devices Companies have an agreement with the Yale Open Data Access (YODA) Project to serve as the independent review panel for evaluation of requests for clinical study reports and participant level data from investigators and physicians for scientific research that will advance medical knowledge and public health.
Requests for access to the study data can be submitted through the YODA project site at http://yoda.yale.edu
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
Yes
product manufactured in and exported from the U.S.
Yes
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cataract
-
Fundación Pública Andaluza para la Investigación...CompletedCataract | Cataract Mature | Cataract, Nuclear
-
Johannes Kepler University of LinzCompletedCataract Complicated | Cataract Complications OperationsAustria
-
Gemini Eye ClinicRecruitingBilateral Cataract | Unilateral CataractCzechia
-
Universitaire Ziekenhuizen KU LeuvenLaboratoires TheaRecruiting
-
Omer Othman AbdullahCompletedCongenital Cataract | Pediatric CataractIraq
-
Johannes Kepler University of LinzRecruitingAphakia | Secondary Cataract Surgery | Complicated Cataract SurgeryAustria
-
Yonsei UniversityCompletedCataract PatientsKorea, Republic of
-
Advanced Center for Eyecare GlobalNot yet recruiting
-
Vienna Institute for Research in Ocular SurgeryRecruiting
-
Zhongshan Ophthalmic Center, Sun Yat-sen UniversityNot yet recruitingCataract ExtractionChina
Clinical Trials on Model DIU
-
Sun Yat-sen UniversityQueen's University, Belfast; Orbis; Aravind Eye Care System; Padmashree Dr. D.... and other collaboratorsCompleted
-
National University, SingaporeUnknown
-
Medtronic CardiovascularCompleted
-
University of ParmaCompletedMotor Activity | Hemiplegic Cerebral PalsyItaly
-
Johnson & Johnson Surgical Vision, Inc.Active, not recruiting
-
University of PittsburghPatient-Centered Outcomes Research InstituteCompletedHearing Loss, Age-RelatedUnited States
-
CORD, LLCTerminated
-
Osmaniye Korkut Ata UniversityCompleted
-
Alcon ResearchCompleted
-
Washington University School of MedicineNational Cancer Institute (NCI)CompletedBiospecimen DonationUnited States